Jeremy P. Springhorn

2017

In 2017, Jeremy P. Springhorn earned a total compensation of $1.8M as Chief Business Officer at Syros Pharmaceuticals.

Compensation breakdown

Option Awards$1,750,956
Salary$53,250
Other$34
Total$1,804,240

Springhorn received $1.8M in option awards, accounting for 97% of the total pay in 2017.

Springhorn also received $53.3K in salary and $34 in other compensation.

Rankings

In 2017, Jeremy P. Springhorn's compensation ranked 6,008th out of 14,666 executives tracked by ExecPay. In other words, Springhorn earned more than 59.0% of executives.

ClassificationRankingPercentile
All
6,008
out of 14,666
59th
Division
Manufacturing
2,205
out of 5,772
62nd
Major group
Chemicals And Allied Products
694
out of 2,075
67th
Industry group
Drugs
536
out of 1,731
69th
Industry
Pharmaceutical Preparations
422
out of 1,333
68th
Source: SEC filing on April 26, 2018.

Springhorn's colleagues

We found two more compensation records of executives who worked with Jeremy P. Springhorn at Syros Pharmaceuticals in 2017.

2017

Nancy Simonian

Syros Pharmaceuticals

Chief Executive Officer

2017

David Roth

Syros Pharmaceuticals

Chief Medical Officer

In-depth

You may also like